NexusPharma, Inc.
Records under this name other than the patents NexusPharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to NexusPharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,426,466 | Compositions and methods for enhancing active agent absorption Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 8,367,699 | Tetrahydro-isoquinolines Lapsed on the fee record Ended Feb 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | From the USPTO record |
| US 8,163,744 | Tetrahydro-isoquinolin-1-ones for the treatment of cancer Lapsed on the fee record Ended Apr 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | From the USPTO record |
| US 9,149,530 | Compositions and methods for enhancing active agent absorption Lapsed on the fee record Ended Oct 6, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 6, 2023 | From the USPTO record |
| US 7,705,021 | Isoindolone Compounds, Compositions Containing the Same, and Methods of Use Thereof for the Treatment of Viral Infections Related to the Etiology of Cancer Formerly held Lapsed on the fee record Ended Apr 27, 2022 · High confidence | Lapsed on the fee record | Ended Apr 27, 2022 | High confidence |